How long does stem cell therapy for Osteoporosis & Bone Health last?
The timing and durability of any benefit are unknown, and periodic retreatment is not an established standard. Bone remodelling and fracture risk require long follow-up, appropriate comparators and prespecified imaging and clinical endpoints. Providers should not promise a response window or maintenance schedule for an unapproved product.
How stem cells are studied for Osteoporosis & Bone Health
Bone continuously remodels through osteoblast and osteoclast activity. Osteoporosis develops when bone strength declines and fracture risk increases because resorption and formation are imbalanced. Mesenchymal stromal cells (MSCs) are being studied because of their osteogenic potential and paracrine signalling in preclinical models. These mechanisms have not established restored bone strength or fewer fractures in people, and cell therapy is not standard osteoporosis care. The registry table on this page lists relevant studies and their current recruitment status.
Am I a candidate? → · Osteoporosis & Bone Health: full overview → · Osteoporosis & Bone Health cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.